The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Fertility and Sterility

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.FERTNSTERT.2005.01.117PMID 16009161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aromatase Inhibitors for Ovulation Induction

  2006cited by this paper
• The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.

  2004cited by this paper
• A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.

  2004cited by this paper
• Effect of Insulin-Like Growth Factor-I During Preantral Follicular Culture on Steroidogenesis, In Vitro Oocyte Maturation, and Embryo Development in Mice1

  2004cited by this paper
• Age = egg quality, FSH level = egg quantity.

  2003cited by this paper
• Ultrasound examination of polycystic ovaries: is it worth counting the follicles?

  2003cited by this paper
• Formation and early development of follicles in the polycystic ovary.

  2003cited by this paper
• Age is a better predictor of pregnancy potential than basal follicle-stimulating hormone levels in women undergoing in vitro fertilization.

  2003cited by this paper
• Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization.

  2003cited by this paper
• Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders.

  2002cited by this paper
• Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging.

  2002cited by this paper
• Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve.

  2002cited by this paper
• American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

  2002cited by this paper
• Antagonist/letrozole protocol for patients failing microdose agonist flare stimulation.

  2002cited by this paper
• American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

  2002cited by this paper
• Gonadotrophin receptor expression on human granulosa cells of low and normal responders to FSH.

  2001cited by this paper
• Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders.

  2001cited by this paper
• Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques.

  2000cited by this paper
• Follicular fluid concentrations of adrenomedullin, vascular endothelial growth factor and nitric oxide in IVF cycles: relationship to ovarian response.

  2000cited by this paper
• High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial.

  2000cited by this paper
• Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary.

  1999cited by this paper
• Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD-SCID mouse.

  1999cited by this paper
• Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development.

  1999cited by this paper
• A rational approach to the management of low responders in in-vitro fertilization.

  1999cited by this paper
• Androgens stimulate early stages of follicular growth in the primate ovary.

  1998cited by this paper
• Effect of androgens on the development of mouse follicles growing in vitro.

  1998cited by this paper
• Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations.

  1998cited by this paper
• Location and developmental regulation of androgen receptor in primate ovary.

  1997cited by this paper
• Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.

  1996cited by this paper
• Endocrinology: Iminunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome

  1996cited by this paper
• High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome.

  1996cited by this paper
• 1 – Hormonal Control of Folliculogenesis and Luteinization

  1994cited by this paper
• The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response.

  1994cited by this paper
• Polycystic ovaries in female-to-male transsexuals.

  1993cited by this paper
• Mechanistic studies on aromatase and related C-C bond cleaving P-450 enzymes.

  1993cited by this paper
• POLYCYSTIC OVARIES IN FEMALE-TO-MALE TRANSSEXUALS

  1993cited by this paper
• 17β‐Oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals *

  1992cited by this paper
• The correlation of interleukin 1 and tumour necrosis factor to oestradiol, progesterone and testosterone levels in periovulatory follicular fluid of in-vitro fertilization patients.

  1992cited by this paper
• Increasing the human menopausal gonadotropin dose‐ does the response really improve?

  1991cited by this paper
• Increasing the human menopausal gonadotropin dose--does the response really improve?

  1990cited by this paper

• A novel therapeutic approach: The effect of letrozole-assisted synchronization on reproductive performance in suckling ewes during the non-breeding season.

  2025cites this paper
• Ovarian response in natural cycle, minimal stimulation and conventional IVF protocols in relation to anti-mullerian hormone level - A multi-center study.

  2025cites this paper
• Evaluation of the effects of the Stop GnRH agonist with the letrozole protocol in poor ovarian responders: ABOTH randomized controlled trial

  2025cites this paper
• Subtle perturbations of ovarian steroidogenesis in patients classified as Poseidon Group 3. Which consequences for therapeutic strategy?

  2024cites this paper
• The Effectiveness of Letrozole Alone or in Combination with Methotrexate in the Management of Ectopic Pregnancy, A Systematic Review and Meta-Analysis

  2024cites this paper
• Cleome arabica L mitigates bisphenol A-induced ovarian dysfunction and inflammation in Wistar rats: biochemical, histopathological, pharmacokinetic, and in silico studies

  2024cites this paper
• Reassessing the impact of letrozole co-administration in controlled ovarian hyperstimulation: findings from a single-center repeated measures study

  2024cites this paper
• The role of Letrozole in IVF treatment: new remedy or old mirage?

  2024cites this paper
• Phytochemicals-based investigation of Rubia cordifolia pharmacological potential against letrozole-induced polycystic ovarian syndrome in female adult rats: In vitro, in vivo and mechanistic approach

  2024cites this paper
• Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction.

  2024cites this paper
• [Ovarian function in patients of childbearing age with systemic lupus erythematosus].

  2024cites this paper
• Impact of letrozole co-treatment in an antagonist protocol for IVF/ICSI: a retrospective study

  2024cites this paper
• Do aromatase inhibitors and tamoxifen affect oocyte numbers retrieved in oocyte or embryo banking cycles?

  2024cites this paper
• Impact of 2.5 mg versus 5 mg letrozole co-treatment in an antagonist protocol for IVF: a retrospective study

  2023cites this paper
• Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy

  2023cites this paper
• Protective effect of wuzibushen recipe on follicular development via regulating androgen receptor in polycystic ovary syndrome model rats

  2023cites this paper
• Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation

  2023cites this paper
• Selenium Nanoparticles Modulate Steroidogenesis-Related Genes and Improve Ovarian Functions via Regulating Androgen Receptors Expression in Polycystic Ovary Syndrome Rat Model

  2023cites this paper
• Effectiveness of letrozole in pituitary downregulated normogonadotrophic young women with an initial poor response

  2023cites this paper
• Gonadotropin Versus Gonadotropin/Letrozole Protocol in Previously Failed Antagonist Cycles in Patients with Low Prognosis

  2023cites this paper
• Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF

  2023cites this paper
• The effect of letrozole as an adjunct in GnRH-antagonist protocol on IVF/ICSI outcome in women with endometriosis: a randomized clinical trial

  2023cites this paper
• Oocyte in-vitro maturation primed with letrozole-HCG versus FSH-HCG in women with oocyte maturation abnormalities: a retrospective study.

  2023cites this paper
• The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better

  2022cites this paper
• Effect of letrozole on follicular fluid steroids concentrations in cancer patients undergoing oocyte cryopreservation

  2022cites this paper
• Evaluation of Anti-Mullerian Hormone in Predicting In Vitro Fertilization Cycle Outcomes

  2022cites this paper
• Age-related changes in Folliculogenesis and potential modifiers to improve fertility outcomes - A narrative review

  2022cites this paper
• A Review on the Use of Letrozole in Female and Male Infertility

  2022cites this paper
• Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer

  2022cites this paper
• The Effect of Clomiphene Citrate and Letrozole in Apoptotic Pathways and Cell Cycle in Human Primary Cumulus Cells and the Protective Effect of Estradiol

  2022cites this paper
• Fertility With Early Reduction of Ovarian Reserve

  2022cites this paper
• Effects of letrozole co-treatment on outcomes of gonadotropin-releasing hormone antagonist cycles in POSEIDON groups 3 and 4 expected poor responders

  2022cites this paper
• The impact of suppressing estradiol during ovarian stimulation on the unsupported luteal phase: a RCT.

  2022cites this paper
• Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen

  2022cites this paper
• Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an "in-vivo" study.

  2022cites this paper
• Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole-Induced Experimental Polycystic Ovary Syndrome

  2022cites this paper
• COMPARED STUDY BETWEEN THE USE OF IETROZOLE AND METHOTREXATE FOR THE MEDICAL TREATMENT OF EARLY SUSPECIOUS UNDISTURBED TUBAL ECTOPIC PREGNANCY

  2022cites this paper
• Letrozole-induced endometrial preparation improved the pregnancy outcomes after frozen blastocyst transfer compared to the natural cycle: a retrospective cohort study

  2022cites this paper
• Effects of letrozole cotreatment on endocrinology and follicle development in women undergoing ovarian stimulation in an antagonist protocol.

  2022cites this paper
• Diverse role of androgen action in human breast cancer

  2022cites this paper
• Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome

  2022cites this paper
• Effects of using letrozole in combination with the GnRH antagonist protocol for patients with poor ovarian response: a meta-analysis.

  2021cites this paper
• A Novel Stimulation Protocol for Poor-Responder Patients: Combining the Stop GnRH-ag Protocol with Letrozole Priming and Multiple-Dose GnRH-ant: A Proof of Concept

  2021cites this paper
• Role of Letrozole in Management of Female Infertility; Review Article

  2021cites this paper
• High serum anti-Müllerian hormone concentrations have a negative impact on fertilization and embryo development rates.

  2021cites this paper
• The pharmacokinetics of letrozole and its effect on gonadotropins in anestrous ewes.

  2021cites this paper
• Letrozole as an adjunct treatment in antagonist cycles that previously failed in poor responders.

  2021influential citation
• Pregnancy outcomes following different protocols of controlled ovarian hyperstimulation in couples undergoing intrauterine insemination

  2021cites this paper
• The impact of estradiol on pregnancy outcomes in letrozole-stimulated frozen embryo transfer cycles

  2021cites this paper
• A Prospective Randomised Comparative Clinical Trial Study of Luteal Phase Letrozole versus Ganirelix Acetate Administration to Prevent Severity of Early Onset OHSS in ARTs

  2021cites this paper
• Letrozole for Female Infertility

  2021cites this paper
• Novel Promising Reproductive and Metabolic Effects of Cicer arietinum L. Extract on Letrozole Induced Polycystic Ovary Syndrome in Rat Model.

  2021cites this paper
• Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis.

  2021cites this paper
• Pasado presente y futuro de la estimulación ovárica en el tratamiento de la infertilidad

  2021cites this paper
• STUDY OF THE EFFECT OF ADDING LETROZOLE TO GONADOTROPIN-RELEASING HORMONE ANTAGONIST PROTOCOL IN POOR RESPONDERS UNDERGOING INTRACYTOPLASMIC SPERM INJECTION

  2021cites this paper
• The Use of Androgen Priming in Women with Reduced Ovarian Reserve Undergoing Assisted Reproductive Technology

  2021cites this paper
• Current Knowledge on the Use of Letrozole in Ovarian Stimulation

  2021cites this paper
• Use of an aromatase inhibitor for ovarian synchronization in cattle

  2020influential citation
• Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer.

  2020cites this paper
• Aromatase is a novel neo-substrate of cereblon responsible for immunomodulatory drugs-induced thrombocytopenia.

  2020cites this paper
• Low dose of gonadotropin with letrozole versus high dose of gonadotropin in patients with poor ovarian response undergoing IVF: a randomised, single-blind, prospective trial

  2020influential citation
• ЕНДОМЕТРІОМИ ЯЄЧНИКІВ І ОВАРІАЛЬНИЙ РЕЗЕРВ

  2020cites this paper
• Androgens for Improving Ovarian Response to Stimulation

  2020cites this paper
• Mining of variables from embryo morphokinetics, blastocyst’s morphology and patient parameters: an approach to predict the live birth in the assisted reproduction service

  2020cites this paper
• Ovarian Stimulation Using Oral Therapy Protocols for the Ovulatory Patient Undergoing Intrauterine Insemination

  2020cites this paper
• Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis

  2020cites this paper
• A review of the physiology behind letrozole applications in infertility: are current protocols optimal?

  2020cites this paper
• An attempt to potentiate the ovarian superstimulatory response in cattle by co-treatment with an aromatase inhibitor.

  2020cites this paper
• Effect of adding letrozole to gonadotropin on in vitro fertilization outcomes: An RCT

  2020cites this paper
• Ameliorative effects of selenium nanoparticles on letrozole induced polycystic ovarian syndrome in adult rats

  2020cites this paper
• Fertility preservation in patients with BRCA mutation

  2020cites this paper
• The Role of Letrozole (LE) in Controlled Ovarian Stimulation (COS) in Patients at High Risk to develop Ovarian Hyper Stimulation Syndrome (OHSS). A prospective randomized controlled pilot study.

  2020cites this paper
• The effects of letrozole on women with endometriosis undergoing ovarian stimulation for in vitro fertilization

  2020cites this paper
• Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?

  2020cites this paper
• Pregnancy Outcomes Following Letrozole Use in Frozen-thawed Embryo Transfer Cycles: A Systematic Review and Meta-analysis

  2020cites this paper
• The stimulation protocol in poor responder IVF; a minimal or high-dose stimulation? – A meta-analysis

  2019cites this paper
• Double mild stimulation and egg collection in the same cycle for management of poor ovarian responders.

  2019cites this paper
• Ovarian Response to Letrozole Combined with Gonadotropin Regimen in Patients with Diminished Ovarian Reserve Candidate for IVF

  2019cites this paper
• A COMPARATIVE STUDY BETWEEN THE EFFECT OF LICORICE ROOTS, MARJORAM AND DATE PALM POLLEN AQUEOUS EXTRACTS AND METFORMIN ON POLY CYSTIC OVARY SYNDROME IN RATS

  2019cites this paper
• Ovarian Stimulation in Women with Breast Cancer

  2019cites this paper
• Letrozole as co-treatment agent in ovarian stimulation antagonist protocol in poor responders: A double-blind randomized clinical trial

  2019cites this paper
• Phyllanthus muellerianus (Euphorbiaceae) Restores Ovarian Functions in Letrozole-Induced Polycystic Ovarian Syndrome in Rats

  2019cites this paper
• Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients

  2019cites this paper
• Food Supplements and Hormonal Products to Improve Assisted Reproductive Technology Outcomes in Patients with Diminished Ovarian Reserve

  2019cites this paper
• Letrozole supplementation during controlled ovarian stimulation in expected high responders: a pilot randomized controlled study

  2019cites this paper
• Androgens and ovarian function: translation from basic discovery research to clinical impact.

  2019cites this paper
• ANDRO-IVF: a novel protocol for poor responders to IVF controlled ovarian stimulation

  2018cites this paper
• 2 Minimal and Natural Stimulations for IVF

  2018cites this paper
• Effect of letrozole added to gonadotropins in controlled ovarian stimulation protocols on the yield and maturity of retrieved oocytes

  2018cites this paper
• Düşük Over Rezervli Hastalarda GnRH Antagonist/Letrozol Stimülasyon Protokolünün Kullanılmasının İntrasitoplazmik Sperm Enjeksiyonu Siklus Sonuçlarına Etkisi

  2018cites this paper
• Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes

  2018cites this paper
• Treatment modalities in poor responder patients undergoing assisted reproductive techniques

  2018cites this paper
• Use of clomiphene or letrozole for treating women with polycystic ovary syndrome related subfertility in Hilla city

  2017cites this paper
• Role of androgens in the ovary.

  2017cites this paper
• Letrozole+ GnRH antagonist stimulation protocol in poor ovarian responders undergoing intracytoplasmic sperm injection cycles: An RCT

  2017cites this paper
• Ovarian reserve testing: a user's guide

  2017cites this paper
• In vitro fertilization treatments with the use of clomiphene citrate or letrozole.

  2017cites this paper
• Does daily co-administration of letrozole and gonadotropins during ovarian stimulation improve IVF outcome?

  2017cites this paper
• Mild Stimulation Protocol for Poor Ovarian Responders Undergoing IVF

  2017cites this paper
• Fertility with early reduction of ovarian reserve: the last straw that breaks the Camel’s back

  2017cites this paper